Abstract

Incarvillea mairei var. grandiflora, a variety of Incarvillea maireia (Bignoniaceae), is distributed mainly in Yunnan, Sichuan, and Qinghai provinces. It often grows in mountains with an altitude of about 2500–3650 meters. Its roots and leaves can be used as folk medicine for the treatment of anemia [1]. In our systematic investigation on the chemical constituents of the whole plant of I. mairei var. grandiflora, 14 compounds were isolated from this plant for the first time. The whole plants of I. mairei var. grandiflora were collected by the Yunnan Gesang Flowering Plants Co. Ltd. in late October 2006, and were authenticated by Prof. Li-shan Xie of Kunming Institute of Botany, Chinese Academy of Sciences. A voucher specimen (No. 2006101020) is deposited in the School of Pharmacy, Second Military Medical University, Shanghai, P. R. China. The whole plants of I. mairei var. grandiflora (8.5 kg) were extracted with methanol at room temperature. The methanol extract was partitioned with petroleum ether, CHCl3, EtOAc, and n-BuOH. Each fraction was purified by column chromatography with silica gel, Rp-18, and Sephadex LH-20 to yield compounds 1–14. The compounds were investigated by spectroscopic methods, including NMR and mass spectrometry. All compounds were identified as rengyolone (1) [2], cleroindicin B (2) [2], cleroindicin C (3) [2], polygalacerebroside (4) [3], schizandrin (5) [4], 1-O-caffeoylglycerol (6) [5], 4-hydroxycinnamic acid (7) [6], isoacteoside (8) [7], eutigoside A (9) [8], caffeic acid ethyl ester (10) [5], -amyrin (11) [9], quercetin (12) [10], quercetin-7-O-rhamnoside (13) [10], and stigmasterol (14) [11]. Rengyolone (Halleridone) (1). Colorless oil, [ ] D –2.56 (c 0.03, MeOH), ESI-MS m/z: 153.0 [M–H]–, 177.1 [M+Na]+. PMR (600 MHz, CDCl3, , ppm, J/Hz): 3.98 (1H, m, H-2a), 3.76 (1H, m, H-2b), 2.24 (1H, m, H-3a), 2.10 (1H, m, H-3b), 6.69 (1H, dd, J = 10.2, 1.5, H-4), 5.87 (1H, d, J = 10.2, H-5), 2.68 (1H, dd, J = 16.8, 4.5, H-6), 2.48 (1H, dd, J = 16.8, 4.2, H-7), 4.12 (1H, dd, J = 4.5, 4.2, H-7a); 13C NMR (150 MHz, CDCl3, , ppm): 65.9 (C-2), 39.1 (C-3), 74.7 (C-3a), 148.9 (C-4), 127.9 (C-5), 197.7 (C-6), 39.7 (C-7), 80.9 (C-7a). Cleroindicin B (2). Colorless oil, EI-MS m/z: 158 [M]+, 140 [M–H2O], 122 [M–2H2O], 112 [140–C2H4]. PMR (300 MHz, DMSO-d6, , ppm, J/Hz): 2.16 (2H, dt, J = 13.2, 4.8, He-2, 6), 1.84 (2H, dt, J = 13.2, 6.2, Ha-2, 6), 2.95 (2H, dt, J = 13.6, 6.2, Ha-3, 5), 2.32 (2H, dt, J = 13.6, 4.8, He-3, 5), 2.05 (2H, t, J = 6.6, H-7), 4.18 (2H, t, J = 6.6, H-8); 13C NMR (75 MHz, DMSO-d6, , ppm): 69.8 (C-1), 37.6 (C-2, 6), 37.8 (C-3, 5), 211.5 (C-4), 44.4 (C-7), 58.8 (C-8). Cleroindicin C (3). Colorless oil, ESI-MS m/z: 157.0 [M+H]+; PMR (500 MHz, CDCl3, , ppm, J/Hz): 3.91 (2H, m, H-2), 2.02 (1H, m, H-3a), 2.07 (1H, m, H-3b), 2.13 (1H, m, H-5a), 2.22 (1H, m, H-5b), 2.32 (1H, ddd, J = 15.8, 10.8, 3.6, H-6a), 2.63 (1H, ddd, J = 11.6, 6.2, 3.4, H-6e), 2.76 (1H, dd, J = 15.7, 4.2, H-8), 2.97 (1H, dd, J = 15.7, 4.2, H-8), 4.25 (1H, t, J = 4.2, H-9); 13C NMR (125 MHz, CDCl3, , ppm): 65.7 (C-2), 39.9 (C-3), 76.9 (C-3a), 32.9 (C-4), 34.8 (C-5), 211.3 (C-6), 42.1 (C-7), 83.1 (C-7a). Polygalacerebroside (4). White powder, ESI-MS: m/z 732.5632 [M+H]+, HR-ESI-MS m/z: 732.5632 [M+H]+ (calcd for C40H78O10N, 732.5626). PMR (500 MHz, DMSO-d6, , ppm, J/Hz): 3.81 (1H, dd, J = 11.0, 7.0, H-1a), 3.67 (1H, m, H-1b), 4.11 (1H, m, H-2), 3.38 (1H, H-3), 3.35 (1H, H-4), 1.93 (2H, H-5), 5.36 (1H, H-6), 5.36 (1H, H-7), 1.93 (2H, H-8), 0.85 (3H, J = 7.0, H-9), 7.50 (1H, d, J = 9.0, H-2-NH-), 3.86 (1H, m, H-2 ), 0.85 (3H, J = 7.0, H-16 ), 1.24~1.60, (44H, H-5–9, 14–17,

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.